Abnormal Glycaemic Fluctuations Associated With Early Microvascular Changes in the Retina and Choroid of Nondiabetic Adults.
Yan Jiang, Liping Gu, Yuhang Ma...
https://pubmed.ncbi.nlm.nih.gov/42271560/Actively Recruiting
Led by Guang Ning · Updated on 2024-12-05
1000000
Participants Needed
1
Research Sites
104 weeks
Total Duration
Researchers are establishing a nationwide prospective database of diabetes patients treated at National Metabolic Management Centers MMCs across China. The study aims to explore epidemiology, genetics, biomarkers, risk factors, and prognostic methods related to diabetes and its complications, as well as other metabolic diseases. It also evaluates current care status, treatment strategies, patient costs, and quality of life to support the Healthy China 2030 strategy. Participants receive standard diabetes management at MMCs, which integrate advanced medical equipment and Internet of Things technology to provide a standardized, convenient, and precise model of care. After a comprehensive baseline evaluation, patients are followed with clinical and laboratory visits every 3 to 6 months based on individualized treatment plans, with yearly comprehensive assessments for glycemic control, risk factors, safety, and diabetes complications. During the study, participants undergo regular clinical and laboratory evaluations including monitoring of blood glucose, blood pressure, lipids, body mass index, and visceral fat. Researchers also assess health-related quality of life, cognitive function, psychological well-being, and cost-effectiveness. The study tracks diabetes-related clinical endpoints such as macrovascular and microvascular morbidity, mortality, infections, heart failure, neuropathy, and cancers, with follow-up lasting up to 20 years.
CONDITIONS
China Diabetes Registry by Metabolic Management Center
G
Guang Ning, MD,PHD
Explore thousands of other clinical trials that might be a better match.
Sign up to get personalized trial recommendations delivered to your inbox.
Already have an account? Log in here
Guang Ning
Lead Sponsor
You may qualify if you...
You will not qualify if you...
Duration - 2 to 4 weeks
Participants are screened for eligibility to participate in the trial.
1 visit (in-person)
Duration - Baseline
Participants undergo a comprehensive baseline evaluation including clinical and laboratory assessments at each Metabolic Management Center.
1 baseline visit (in-person)
Duration - Up to 20 years
Participants are followed with clinical and laboratory visits every 3 to 6 months based on individualized treatment plans, with repeated comprehensive annual assessments to monitor diabetes management, complications, and quality of life.
Visits every 3 to 6 months with comprehensive assessments once a year
Study Type
OBSERVATIONAL
Masking
N/A
Allocation
N/A
Model
N/A
Primary Purpose
N/A
Number of Arms
1
Have more questions? Get in touch with our team for quick support
Yan Jiang, Liping Gu, Yuhang Ma...
https://pubmed.ncbi.nlm.nih.gov/42271560/Lin Mu, Chao Li, Wenying Zhao...
https://pubmed.ncbi.nlm.nih.gov/38131034/Li Li, Yuwei Mi, Miao Xu...
https://pubmed.ncbi.nlm.nih.gov/35784580/Yifei Zhang, Weiqing Wang, Guang Ning
https://pubmed.ncbi.nlm.nih.gov/30284373/Xi Yang, Yi Lin, Guo-Dong Xu...
https://pubmed.ncbi.nlm.nih.gov/33790605/Juan Shi, Dong Zhao, Jing Wang...
https://pubmed.ncbi.nlm.nih.gov/41991218/Guang Ning
Lead Sponsor